A study led by the Clínic Barcelona Comprehensive Cancer Center —a center driven by Clínic-IDIBAPS and the University of Barcelona (UB)— demonstrates how a CAR-T therapy designed at the center c...
Read moreCada 22 de septiembre se conmemora el Día Mundial de la Leucemia Mieloide Crónica, una fecha clave para visibilizar la enfermedad y destacar la importancia de la investigación, la detección precoz...
Read moreIn the complex world of pharmaceutical and biotechnology drug development, PIVOTAL serves as your trusted medical partner – delivering expert medical oversight and strategic insight across every pha...
Read moreLa Fundación ”la Caixa” ha seleccionado dos proyectos del Cima Universidad de Navarra dentro de la convocatoria 2025 del programa CaixaImpulse, iniciativa que financia propuestas biomédicas nove...
Read more"La Caixa" Foundation will allocate €150,000 to the project led by Alba Rodríguez, from the IDIBAPS Cellular Immunotherapies for Cancer research group. It involves a study that aims to develop a ne...
Read moreThe KIMA genomic signature identifies patients with HR+/HER2– breast cancer who have a lower response to CDK4/6 inhibitors, enabling more personalized treatments
Read moreThe research has been carried out in conjunction with Stanford University and has enabled designing a screening system to identify extremely selective peptides with therapeutic potential that minimize...
Read moreCuando las células de sarcoma de Ewing son infectadas por el adenovirus terapéutico, estas expresan el gen ‘suicida’ HSV-TK. Este gen es inocuo, pero cuando se combina con la prodroga ganciclovi...
Read moreThe study, published in Molecular Oncology, reveals that the gene TCF19 plays a critical role in prostate cancer progression, tumor growth, and metastatic spread, highlighting its potential as a progn...
Read moreDebido al envejecimiento que justo a esa edad produce cambios significativos en la barrera hematoencefálica que protege el Sistema Nervioso Central
Read moreWhen your imaging must be precise and reliable, CJ215 delivers. This next-generation tumour-labelling dye is validated across multiple models ; breast, pancreatic, prostate, colon and fibrosarcoma ; s...
Read moreLa combinación de la inmunoterapia con nivolumab al tratamiento clásico de radioterapia y quimioterapia después de una cirugía, mejora la supervivencia libre de enfermedad y podría transformar la...
Read more